Paired Integrative Home Exercise for Seniors With Dementia and Their Caregivers (PairedPLIE) (PairedPLIE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02403752 |
Recruitment Status :
Completed
First Posted : March 31, 2015
Last Update Posted : December 19, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Specific Aim 1: To determine feasibility of a 20-minute dyadic exercise program for ambulatory individuals with dementia and caregivers living at home based on recruitment, adherence and retention. Investigators will conduct a pilot randomized controlled trial (RCT) with 20 dyads (total N = 40) in groups of 5 randomized to 16-week group exercise classes and regular home practice or wait list in a cross-over design. Investigators will assess feasibility of enrollment and retention, the proportion of completed outcome measures, and adherence by class attendance logs, caregiver-reported home practice logs and qualitative interviews to assess ease of implementation in the home environment. Investigators will explore feasibility of weekly phone calls to (potentially overwhelmed) caregivers and Fit-bit accelerometers as a measure for tracking home practice.
Specific Aim 2: To collect preliminary effect size data for sample size calculation for a larger trial. Investigators will assess standard outcomes (such as the Short Physical Performance Battery and Alzheimer's Disease Assessment Scale - cognitive subscale as primary outcomes for affected individuals; and Caregiver Burden Inventory for caregivers) commonly used in pharmacological studies of individuals with dementia at baseline, 16 and 32 weeks and calculate effect sizes (Cohen's d) for between-group differences in outcome changes in the 20 dyads of the RCT described in Specific Aim 1.
Specific Aim 3: To explore the feasibility of using non-invasive Near-Infrared Spectroscopy (NIRS) to assess regional cortical brain oxygenation and its sensitivity to change. Investigators will compare brain oxygenation variations before and after the exercise intervention during a memory task for the seniors with dementia.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Dementia Alzheimer's Disease | Behavioral: Paired PLIE Program | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 20 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Paired Integrative Home Exercise for Seniors With Dementia and Their Caregivers |
Study Start Date : | March 2015 |
Actual Primary Completion Date : | July 2018 |
Actual Study Completion Date : | July 2018 |

Arm | Intervention/treatment |
---|---|
Experimental: exercise intervention
Exercise protocol based on the PLIÉ protocol, developed in consultation with experts worldwide, incl. traditional strength-building exercises, yoga, Tai Chi and Feldenkrais, that engage the muscles most needed to maintain independence--including lower body strength, balance, upper body strength, fine motor exercises , and pelvic floor exercises- combined them into a unique integrative exercise program, to be purposeful and to build procedural ('muscle') memory. To be practiced at home in dyads of affected individuals and caregivers, called Paired PLIE Program. |
Behavioral: Paired PLIE Program
Integrative exercise as described above |
- Change in Short Physical Performance Battery (SPPB) from Baseline to 4 months [ Time Frame: Baseline, post-intervention (4 months) ]We will perform a variety of standard measures in all participants and caregivers. Assessments will occur at baseline, after the 4 months of intervention, and at 8 months after follow-up of 4 months. Outcomes will primarily be utilized to assess feasibility and logistics of data collection procedures.
- Change in Alzheimer's Disease Assessment Scale - cognitive subscale (ADAS-cog) from baseline to 4 months [ Time Frame: Baseline, post-intervention (4 months) ]We will perform a variety of standard measures in all participants and caregivers. Assessments will occur at baseline, after the 4 months of intervention, and at 8 months after follow-up of 4 months. Outcomes will primarily be utilized to assess feasibility and logistics of data collection procedures.
- Change in Quality of Life Scale in Alzheimer's Disease (QOL-AD) from baseline to 4 months [ Time Frame: Baseline, post-intervention (4 months) ]same as above
- Change in Caregiver Burden Inventory (CBI) from baseline to 4 months [ Time Frame: Baseline, post-intervention (4 months) ]same as above

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Affected individuals: dementia diagnosis (any type, mild to moderate severity [defined as independent in at least 1 basic ADL])
- Ambulatory and able to take 2 steps without cane or walker
- Living in the community in a private home or apartment
- English language fluency.
- Caregiver/care partner: lives with affected individual
- Motivated to practice regularly (4-5 times per week) at home
- Able to answer study questions related to the affected individual's functional status, mood, behaviors, quality of life and their own feelings regarding caregiving
- English language fluency.
Exclusion Criteria:
- Affected Individuals: behavioral or physical issues that would be disruptive or dangerous to themselves or others (e.g., active psychosis, drug abuse, severe behavioral issues)
- Planning to move to a facility before the end of the study period
- Terminal illness (life expectancy < 1 year)
- Non-stable dementia medication dose
- Current participation in another research study.
- Caregiver/care partner: planning to place affected individual in an institutional setting during the study period
- Terminal illness (life expectancy < 1 year)
- Behavioral or physical issues that are disruptive or dangerous.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02403752
United States, California | |
UCaliforniaSF | |
San Francisco, California, United States, 94115 |
Principal Investigator: | Wolf E Mehling, MD | University of California, San Francisco |
Other Publications:
Responsible Party: | University of California, San Francisco |
ClinicalTrials.gov Identifier: | NCT02403752 |
Other Study ID Numbers: |
14-14943 |
First Posted: | March 31, 2015 Key Record Dates |
Last Update Posted: | December 19, 2018 |
Last Verified: | December 2018 |
dementia Alzheimer's disease exercise |
Alzheimer Disease Dementia Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Tauopathies Neurodegenerative Diseases Neurocognitive Disorders Mental Disorders |